Home
                       
Contact us Home         Search   go
Company News
Purdue's 10 Point
    Program
Media Contacts

Welcome to the Purdue Newsroom

In this section you will find recent news and events pertaining to Purdue Pharma L.P. and its family of products.

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

2010
Statement of Purdue Pharma L.P. Regarding OxyContin® (oxycodone HCl controlled-release) Tablets Risk Evaluation and Mitigation Strategy07/29/2010
Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members07/12/2010
Purdue Pharma L.P. Receives FDA Approval for Butrans™ (buprenorphine) Transdermal System CIII07/01/2010
In the Face of Pain® Offers Social Media 101 for Pain Management Advocates06/02/2010
Statement of Purdue Pharma L.P. Regarding FDA's Approval of Reformulated OxyContin® (oxycodone HCl controlled-release) Tablets04/05/2010
Purdue Pharma L.P. Launches New Pain Management Resource For Healthcare Professionals03/31/2010
Lee Woodruff Helps Shed Light on Chronic Pain, an Urgent Health Issue Facing Many Military Heroes & Their Families 03/31/2010
Purdue Pharma Provides Aid to Victims of Earthquake Disaster in Haiti01/20/2010
Family Caregivers Can Overcome the Challenges of Chronic Pain01/05/2010

2009
Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Reduce Pharmacy Crime10/22/2009
NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to support State Prescription Drug Monitoring Programs10/21/2009
Richard Logan Receives 2009 NCPA Prescription Drug Safety Award10/19/2009
Purdue Pharma L.P. Receives 2009 NCPA Corporate Recognition Award10/19/2009
Statement of Purdue Pharma L.P. Regarding Joint Meeting of the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee09/24/2009
Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo® in the United States08/02/2009
Purdue Pharma L.P. Presents Phase 3 Study of Transdermal Delivery of Buprenorphine in Moderate to Severe Pain05/07/2009
New Once-Daily RYZOLT™ (tramadol HCl extended-release tablets) Now Available in the U.S.05/07/2009

2008
Purdue Pharma L.P. Announces A Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery And Development Programs in Oncology And Neuropathic Pain11/20/2008
Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Mallinckrodt Inc.09/02/2008
Online Tool Helps Pain Advocacy Community Address Growing Public Health Crisis07/24/2008
Purdue Pharma L.P. Supports Enhanced PhRMA Code on Interactions with Healthcare Professionals07/15/2008
Statement of Purdue Pharma Regarding Joint Meeting of the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee05/05/2008
Statement of Purdue Pharma L.P. in Response to the Decision Confirming the Enforceability of its OxyContin Patents01/07/2008

2007
Statement of Purdue Pharma Regarding July 20 Proceedings in the United States District Court for the Western District of Virginia07/20/2007
John H. Stewart Named Acting President of Purdue Pharma L.P.06/25/2007
Information on Resolution of Investigation by United States Attorney's Office, Western District of Virginia05/10/2007
Purdue Pharma L.P. Announces Agreement to End OxyContin® Patent Lawsuit with IMPAX Laboratories04/02/2007

2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin® Tablets Patent Lawsuit with Teva Pharmaceuticals10/16/2006
Purdue Pharma L.P. Announces Agreement to End OxyContin® Patent Lawsuit with Teva Pharmaceuticals08/29/2006
Purdue Pharma L.P. Announces Resolution of OxyContin® Patent Lawsuit with Endo Pharmaceuticals08/28/2006
Statement of Purdue Regarding Endo Patent Decision02/01/2006
Purdue Pharma L.P. and Denver Health Announce Agreement on National Surveillance System to Monitor Abuse and Diversion of Prescription Medications01/12/2006
Purdue Pharma L.P. and Shionogi Sign Multi-Year Research and Worldwide Co-Marketing Agreement for Novel Analgesic Drug Compounds01/10/2006
OxyContin® Dismissals and Withdrawals Exceed 40001/05/2006

2005
New Drug Application for Once-Daily Tramadol Pain Medication Submitted by Purdue's Marketing Partner11/30/2005
SupplyScape and Unisys Pilot Pharmaceutical Industry's First Electronic Pedigree System for Commercial Drugs05/31/2005
Cincinnati Crime Stoppers Partners with Purdue Pharma to Help Solve Pharmacy Crimes Across the Country05/26/2005
New Study Reveals National Limitations and Racial Disparities in Access to Pain Care____- En Español05/24/2005
Michael Friedman, President & CEO of Purdue Pharma, to Receive 2005 Heart of Gold Award05/17/2005
FBI-LEEDA Recognizes Purdue Pharma for Innovative Contributions to Law Enforcement03/29/2005
Purdue Pharma Sponsors Education Program to Raise Awareness of Prescription Drug Abuse in 16,000 Middle Schools03/21/2005
Purdue Pharma L.P. Receives APhA H.A.B. Dunning Award for 200502/16/2005
Purdue Provides Aid to Victims of Tsunami Disaster in Southeast Asia01/06/2005

2004
Purdue Pharma Donates Antibiotics Valued at $50 Million to AmeriCares12/22/2004
Purdue Pharma L.P. Implements Radio Frequency ID System for Drug Packaging to Deter Counterfeiting and Diversion11/15/2004
Purdue Pharma Awards Ten New Communities That Care® Grants 09/20/2004
David Lundie Named Vice President, Plant Manager for Purdue Pharmaceuticals L.P. in Wilson, NC08/16/2004
Purdue Pharma Sponsors New Education Program To Raise Awareness Of Prescription Drug Abuse In 13,000 Middle Schools06/14/2004
$50,000 Purdue Pharma Prize for Pain Research Awarded to Professor Gerald Gebhart04/30/2004
Purdue Pharma Takes Leadership Role in Fairfield County Science Education04/28/2004
CL&P Partners with Purdue Pharma to Save Energy, Money04/23/2004
Former Merck Exec Named Vice President, Corporate Compliance for Purdue Pharma04/08/2004
RxPATROL™ Expands Beyond Prescription Medication Robberies to Include Theft of Over-the-Counter Products04/07/2004
ICC Announces Purdue Pharma as Recipient of the 2004 Leap of Faith Award03/27/2004
Purdue Files Petition with FDA Requesting Risk Management Plans for All Generic Forms of OxyContin01/09/2004

2003
Purdue Pharma Sponsors Ten Communities That Care® Locations - Grants Total $250,00012/18/2003
Chronic Pain Pervasive in All Age Groups, New Study Shows09/04/2003
RxPatrol Initiative Launched to Prevent Pharmacy Theft06/18/2003
Purdue Pharma Appoints Jack Crowley to Oversee Compliance for Handling of Controlled Substances05/21/2003
Purdue Pharma Awarded 'Supplier of the Year' Distinction From AmerisourceBergen01/21/2003

2002
Purdue Acquires Colace®, Peri-Colace®, and Slow-Mag® Products from Shire12/30/2002
Aaron Graham Named Vice President, Corporate Security for Purdue Pharma08/26/2002
APhA and Purdue Announce Pain Management Partnership Campaign08/12/2002
Purdue Pharma Dedicates State-of-the-Art Research Center in New Jersey's Pharma Corridor06/25/2002
Purdue Pharma Supports Effort to Combat Prescription Drug Abuse and Pharmacy Robberies in Massachusetts04/30/2002
$50,000 Purdue Pharma Prize for Pain Research Awarded to Dr. William D. Willis04/24/2002
 
Show Recent Only...
 


Please click here for Legal Restrictions and Terms of Use applicable to this site.
Use of this site signifies your agreement to the terms of use.
Privacy Policy
Copyright 2010 Purdue Pharma L.P.